TSP-2 Composition for Chondrogenic Differentiation

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current therapies for cartilage injuries and degenerative arthritis lack effective methods for stimulating chondrogenic differentiation of stem cells, particularly in association with thrombospondin-2 (TSP-2), which is essential for cartilage repair and regeneration.

Innovation Solution

A composition comprising TSP-2, either naturally produced by stem cells or administered, is used to stimulate chondrogenic differentiation, including umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs), to promote cartilage repair and regeneration, utilizing a carrier like hyaluronic acid or hydroxyapatite to support cell activity and structure.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional therapies (anti-inflammatory agents, COX-2 inhibitors, hydrocortisone, glucosamine, chondroitin sulfate) are used to treat cartilage injury or degenerative arthritis, then pain relief is achieved, but effective cartilage repair and regeneration do not occur

Engineering Contradiction:

Improvetherapeutic effectiveness for cartilage repairVSAvoidlack of chondrogenic differentiation stimulation

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent introduces TSP-2 as an intermediary substance that mediates between conventional therapies and stem cells to achieve chondrogenic differentiation. TSP-2 acts as a signaling molecule that stimulates stem cells to differentiate into chondrocytes, thereby enabling cartilage repair while complementing the pain relief effects of conventional therapies

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the therapeutic parameter from单纯 pain management to active cartilage regeneration by introducing TSP-2. This parameter change transforms the treatment approach from symptomatic relief to disease-modifying therapy that promotes actual cartilage repair through stem cell differentiation

Inventive Principle:

Principle #35Parameter changes

2Reliability

If stem cells are used for cartilage repair, then regenerative potential is achieved, but effective chondrogenic differentiation is not stimulated without TSP-2

Engineering Contradiction:

Improvechondrogenic differentiation capabilityVSAvoidneed for additional growth factors or complex culture conditions

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and isolates TSP-2 as a specific active component that can be administered separately from complex growth factor cocktails. By identifying TSP-2 as the key differentiator, the patent simplifies the treatment approach while maintaining effective chondrogenic differentiation capability

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

TSP-2 serves multiple functions: it acts as an extracellular matrix component, a signaling molecule for stem cell differentiation, and a potential therapeutic agent. This multi-functionality reduces the need for multiple separate treatments or complex culture conditions to achieve cartilage repair

Inventive Principle:

Principle #6Universality (Multi-functionality)

Data Source

PatentEP2752483B1TSP-1, TSP-2, IL-17BR and HB-EGF associated with stem cell activities and applications thereof

Publication Date: 2018.01.17 MEDIPOST

Figure 1
Figure 2
Figure 3

AI summary

An exemplary embodiment of the present invention provides TSP-1, TSP-2, IL-17BR and HB-EGF associated with stem cell activities and applications thereof.